BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35214002)

  • 1. Factors Influencing the Crystallization-Onset Time of Metastable ASDs.
    Wolbert F; Fahrig IK; Gottschalk T; Luebbert C; Thommes M; Sadowski G
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Shelf Life of ASDs: 1. Measuring the Crystallization Kinetics at Humid Conditions.
    Wolbert F; Nikoleit K; Steinbrink M; Luebbert C; Sadowski G
    Mol Pharm; 2022 Jul; 19(7):2483-2494. PubMed ID: 35729680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Water Sorption and Crystallization in ASDs 1: Stability Studies Lasting for Two Years.
    Grönniger B; Kimpe K; Singh A; Sadowski G
    Mol Pharm; 2024 Feb; 21(2):957-969. PubMed ID: 38173336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The shelf life of ASDs: 2. Predicting the shelf life at storage conditions.
    Wolbert F; Luebbert C; Sadowski G
    Int J Pharm X; 2023 Dec; 6():100207. PubMed ID: 37680879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water Sorption in Rubbery and Glassy Polymers, Nifedipine, and Their ASDs.
    Grönniger B; Fritschka E; Fahrig I; Danzer A; Sadowski G
    Mol Pharm; 2023 Apr; 20(4):2194-2206. PubMed ID: 36847428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscosity of ASDs at humid conditions.
    Wolbert F; Stecker J; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2020 Sep; 154():387-396. PubMed ID: 32717391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-situ determination of crystallization kinetics in ASDs via water sorption experiments.
    Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2018 Jun; 127():183-193. PubMed ID: 29477357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscoelastic Behavior of Supercooled and Glassy ASDs at Humid Conditions Can Be Predicted.
    Grönniger B; Danzer A; Kimpe K; Singh A; Sadowski G
    Mol Pharm; 2023 May; 20(5):2568-2578. PubMed ID: 37027344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
    Myślińska M; Stocker MW; Ferguson S; Healy AM
    J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
    Dohrn S; Kyeremateng SO; Bochmann E; Sobich E; Wahl A; Liepold B; Sadowski G; Degenhardt M
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated stability modeling of recrystallization from amorphous solid Dispersions: A Griseofulvin/HPMC-AS case study.
    Leon AS; Waterman KC; Wang G; Wang L; Cai T; Zhang X
    Int J Pharm; 2024 May; 657():124189. PubMed ID: 38701906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Water-Induced Amorphous Phase Separation in Amorphous Solid Dispersions via Raman Mapping.
    Krummnow A; Danzer A; Voges K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.